Showing 3537–3552 of 7558 results
Sulfaquinoxaline sodium (N’1-quinoxalin-2-ylsulphanilamide sodium, SQ-Na) is the sodium salt of sulfaquinoxaline, which is often used as a drug to prevent coccidiosis in poultry, swine, and sheep by inhibiting the synthesis of nucleic acids and proteins in microorganisms.
Dihydralazine sulphate is a dihydralazine-l,4-phthalazine derivative and used as an antihypertensive drug.
Etofylline is a N-7 substituted theophylline derivative used as a bronchodilator.
4-Aminopyridine (4-AP) is a potent and non-selective inhibitor of voltage gated potassium channels (Kv) with IC50 values of 170 μM and 230 μM for Kv1.1 and Kv1.2 in CHO cells, respectively.
Mebeverine, a 3-phenylethylamine derivative of methoxybenzamine, acts as a musculotropic antispasmodic agent.
Efinaconazole is an inhibitor of 14 alpha-demethylase which is involved in the biosynthesis of ergosterol, a constituent of fungal cell membranes.
Miriplatin is a derivative of cisplatin containing myristates as a carrier ligand. It is a novel lipophilic platinum complex developed to treat hepatocellular carcinoma.
Nadolol is a non-selective beta-adrenergic antagonist with antihypertensive and antiarrhythmic activities.
Cefalexine EP Impurity B is used in the synthesis of cephalosporins and for bioconversion studies.
Tilorone dihydrochloride is a broad-spectrum, orally active antiviral agent that activates interferon production. It has antitumor, anti-inflammatory properties.
Indobufen is a reversible platelet aggregation inhibitor. It inhibits the platelet cyclooxygenase enzyme and suppresses thromboxane synthesis.
Mebhydrolin Napadisylate is classified as an antihistamine drug classes used to treat allergies.
Oxyclozanide is a salicylanilide anthelmintic and mitochondrial uncoupling anthelmintic drug approved for veterinary use.
Isoprinosine is an immunopharmacologic agent with antiviral activities.
Simeprevir is a competitive, reversible, macrocyclic, noncovalent hepatitis C virus (HCV) NS3/4A protease inhibitor that acts directly against the hepatitis C virus. It has a medium inhibitory concentration (IC50) <13 nM for all HCV NS3/4A enzymes(genotypes 1a, 1b, 2, 4, 5, and 6), but has an IC50 value of 37 nM for genotype 3.
Crisaborole is a small-molecule, boron-based, selective PDE4 inhibitor and has broad-spectrum anti-inflammatory activity.